share_log

Yellow Stem Enhances Distribution Agreement With Sweet Poison

Yellow Stem Enhances Distribution Agreement With Sweet Poison

Yellow Stem 與甜毒加強了分銷協議
newsfile ·  2023/05/15 14:30

Vancouver, British Columbia--(Newsfile Corp. - May 15, 2023) - Yellow Stem Tech Inc. (CSE: YY) ("Yellow Stem" or the "Company") is pleased to make the following announcements:

溫哥華,不列顛哥倫比亞省-(Newsfile Corp.-2023年5月15日)-黃莖科技公司。(CSE:YY)(“黃莖”或“公司”)高興地宣佈:

As disclosed in December, 2022, the Company signed both a Product Distribution Agreement (the "Distribution Agreement") and an Option Agreement with Sweet Poison Spirits S de RL de CV, a Mexican company headquartered in Guadalajara, Mexico, and Sweet Poison Spirits LLC, a California limited liability corporation headquartered in San Diego, California (collectively, "Sweet Poison"). The Distribution Agreement granted the Company the worldwide distribution rights to Sweet Poison's premium Tequila and Mezcal products under the "Sweet Poison" brand names for an initial period of ten years, renewable for a further ten years and beyond. The Option Agreement grants the Company the right to acquire Sweet Poison in the future for U.S. one million dollars.

於2022年12月披露,本公司與總部位於墨西哥瓜達拉哈拉的墨西哥公司S de RL de CV及總部位於加州聖地亞哥的加州有限責任公司Sweet Poison Spirits LLC(統稱為“Sweet Poison”)簽署了產品分銷協定(“分銷協定”)及期權協定。經銷協定授予該公司“甜毒”品牌的優質龍舌蘭酒和Mezcal產品的全球經銷權,最初為期十年,可續期十年或更長時間。根據期權協定,該公司有權在未來以100萬美元收購Sweet Poison。

The Company has now reached agreement with Sweet Poison, amending both the Distribution Agreement and the Option Agreement to include the acquisition of Sweet Poison's formula for one blend of Sweet Poison's tequila and four blends of mezcal. The Company can now more effectively execute its marketing plans, solidly backed by worldwide distribution rights to Sweet Poison spirits, and ownership of the proprietary formulas for the tequila and mezcal. The cost of acquiring the formulas will be deducted from the purchase price under the Option Agreement, in the event the Company exercises the option.

該公司現已與Sweet Poison達成協定,修改了分銷協定和期權協定,包括收購Sweet Poison的配方,用於一種Sweet Poison龍舌蘭酒和四種Mezcal的混合。該公司現在可以更有效地執行其營銷計劃,這得到了甜毒酒的全球銷售權和龍舌蘭酒和梅斯卡爾酒專利配方的所有權的堅實支持。在公司行使期權的情況下,購買公式的成本將從期權協定項下的購買價格中扣除。

In consideration for acquiring the formulas, the Company will issue to Sweet Poison a total of 2,500,000 post-consolidated shares at a deemed price of $0.10, with hold periods as follows:

作為收購這些公式的代價,該公司將以0.10美元的價格向Sweet Poison發行總計250萬股合併後股票,持有期如下:

  1. 25% of the Shares will become free-trading four months following the date of issuance (the "Closing");

  2. an additional 25% of the Shares will become free-trading 12 months following Closing;

  3. an additional 25% of the Shares will become free-trading 18 months following Closing; and

  4. the remaining 25% of the Shares will become free-trading 24 months following Closing.

  1. 自發行之日起四個月(“收盤”),25%的股份將可以自由交易;

  2. 另外25%的股份將在交易結束後12個月內自由交易;

  3. 另外25%的股份將在交易結束後18個月內自由交易;以及

  4. 其餘25%的股份將在交易結束後24個月內自由交易。

A finder's fee of 250,000 post-consolidated shares will be issued related to this transaction for the finder's efforts in negotiating and facilitating the transaction, such shares to be restricted in the same manner as those shares to be issued to Sweet Poison.

與這筆交易相關的250,000股合併後的發起人股票將被髮行,以表彰發起人在談判和促進交易方面所做的努力,這些股票將受到與向Sweet Poison發行的股票相同的方式的限制。

Name Change Proposed

建議更改名稱

To demonstrate its commitment to the Sweet Poison goals and objectives, the Board of Directors has approved changing the Company's name from Yellow Stem Technologies Inc. to Sweet Poison Spirits Inc. The Company is proceeding with meeting all of the regulatory requirements related to a name change, and will confirm the effective date upon receipt of regulatory acceptance.

為了表明其對甜毒劑的目標和目標的承諾,董事會已批准將公司的名稱從黃色莖技術公司改為甜毒烈酒公司。該公司正在著手滿足與更名相關的所有監管要求,並將在收到監管接受後確認生效日期。

Private Placement

私募

To meet the milestones and business objectives as disclosed in its Listing Statement as filed with the CSE and on SEDAR (see news release of March 28, 2023) the Company announces that it has arranged a non-brokered private placement of up to $1 million (the "Financing") through the issuance of up to 10 million units (the "Units") at a price of $0.10 per Unit. Each Unit will be comprised of one common share and one-half of one common share purchase warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one common share at a price of $0.25 per share for a period of 24 months from closing, provided that, if after the expiry of all resale restrictions, the closing price of the Company's Shares is equal to or greater than $0.40 per share for 30 consecutive trading days, the Company may, by notice to the Warrant holders (which notice may be by way of general news release), reduce the remaining exercise period of the Warrants to not less than 30 days following the date of such notice.

為達到其提交予聯交所及SEDAR的上市說明書所披露的里程碑及業務目標(見2023年3月28日的新聞稿)本公司宣佈,已安排以每單位0.10美元的價格發行至多1,000萬個單位(“單位”),以非經紀私募方式配售至多100萬美元(“融資”)。每個單位將由一股普通股和一半的普通股認購權證(“認股權證”)組成,每份認股權證賦予持有人以每股0.25美元的價格購買一股普通股的權利,為期24個月,為期24個月,條件是,如果在所有轉售限制到期後,公司股份的收盤價連續30個交易日等於或大於每股0.40美元,本公司可以向認股權證持有人發出通知(通知可以是一般新聞稿的方式),將認股權證的剩餘行使期限縮短至不少於該通知日期後的30天。

The Company may pay finders' fees of up to 8% in cash and 8% in half warrants for subscriptions attributable to finders. Finders' warrants will be valid for a period of two years, with each warrant exercisable on the same terms as the Warrants sold under the Financing.

對於可歸因於發現者的認購,該公司可支付最高8%的現金和8%的認股權證的發起人費用。尋獲人認股權證的有效期為兩年,每份認股權證可按與根據融資出售的認股權證相同的條款行使。

The net proceeds of the Financing will be budgeted as follows:

融資的淨收益將編入如下預算:

Use of Funds Amount (C$)
Costs associated with regulatory filings and related approvals 50,000
Formulation of initial marketing and distribution plans 50,000
Costs related to signing up distribution agents in North & South America and Europe. 50,000
Purchase of initial inventory for distribution (excluding sales) 500,000
G & A expenses 164,000
Costs of financing 80,000
Working Capital 106,000
Total $1,000,000
資金的使用 金額(加元)
與監管備案和相關審批相關的成本 50,000
制定初步的營銷和分銷計劃 50,000
與北美、南美和歐洲的分銷代理簽約相關的成本。 50,000
採購初始庫存以供分配(不包括銷售) 500,000
並購費用 164,000
融資成本 8萬
營運資金 106,000
總計 100萬美元

There is no material fact or material change about the Company that has not been generally disclosed.

本公司並無任何重大事實或重大變動未予一般披露。

About Sweet Poison Spirits:

關於甜毒烈酒:

Sweet Poison Spirits are creators and distributors of premium quality spirits. The company is committed to respecting traditional and ancestral processes, sustainability and the environment. For more on Sweet Poison, visit .

甜毒烈酒是優質烈酒的創造者和分銷商。該公司致力於尊重傳統和祖傳工藝、可持續性和環境。欲瞭解更多有關甜蜜毒藥的資訊,請訪問。

ON BEHALF OF THE BOARD

我代表董事會

(Sgd.) "Robert Eadie"
Robert Eadie, President, Chief Executive Officer and Director

(SGD.)《羅伯特·伊迪》
羅伯特·伊迪,董事首席執行官總裁

FOR FURTHER INFORMATION PLEASE CONTACT:
Telephone: 1-604-602-4935 Facsimile: 1-604-602-4936
Contact: Robert Eadie

欲瞭解更多資訊,請聯繫:
電話:1-604-602-4935傳真:1-604-602-4936
聯繫人:羅伯特·伊迪

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其監管服務提供商(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Certain statements and information herein, including all statements that are not historical facts, contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to closing of agreements and future operations.

本新聞稿中的某些陳述和資訊,包括所有非歷史事實的陳述,均包含適用證券法所指的前瞻性陳述和前瞻性資訊。這類前瞻性陳述或資訊包括但不限於與結束協定和未來業務有關的陳述或資訊。

Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. There is no assurance the Company will be able to execute its distribution plans profitably, or at all. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

前瞻性陳述和資訊的性質是基於假設的,涉及已知和未知的風險、不確定因素和其他因素,這些風險、不確定因素和其他因素可能會導致公司的實際結果、業績或成就與此類前瞻性陳述或資訊明示或暗示的任何未來結果、業績或成就大不相同。不能保證該公司能夠有利可圖地執行其分銷計劃,或者根本不能保證。除非依照適用的證券法,否則公司不承諾更新任何前瞻性資訊。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論